EIF4E3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82987
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for EIF4E3 Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human EIF4E3. Peptide sequence: VQVWNVNASLVGEATVLEKIYELLPHITFKAVFYKPHEEHHAFEGGRGKH The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for EIF4E3 Antibody
![Western Blot: EIF4E3 Antibody [NBP2-82987]](https://resources.bio-techne.com/images/products/EIF4E3-Antibody-Western-Blot-NBP2-82987-img0001.jpg "Western Blot: EIF4E3 Antibody [NBP2-82987]")
Western Blot: EIF4E3 Antibody [NBP2-82987]
Western Blot: EIF4E3 Antibody [NBP2-82987] - Host: Rabbit. Target Name: EIF4E3. Sample Tissue: Human DLD1. Antibody Dilution: 1.0ug/mlApplications for EIF4E3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: EIF4E3
Alternate Names
eIF4E type 3, eIF-4E type 3, eIF-4E3, eIF4E-3, eukaryotic translation initiation factor 4E family member 3, eukaryotic translation initiation factor 4E member 3, eukaryotic translation initiation factor 4E type 3, MGC39820, MGC86971
Gene Symbol
EIF4E3
Additional EIF4E3 Products
Product Specific Notices for EIF4E3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...